1. The inhibitor of mitochondrial pyruvate transport oc-cyano-f-(1-phenylindol-3-yl)-acrylate was used to inhibit progressively pyruvate carboxylation by liver mitochondria from control and glucagon-treated rats. The data showed that, contrary to our previous conclusions [Halestrap (1978) Biochem. J. 172, 389-398], pyruvate transport could not regulate metabolism under these conditions. 2. This was confirmed by measuring the intramitochondrial pyruvate concentration, which almost equilibrated with the extramitochondrial pyruvate concentration in control mitochondria, but was significantly decreased in mitochondria from glucagon-treated rats, where rates of pyruvate metabolism were elevated. 3. Computer-simulation studies explain how this is compatible with linear Dixon plots of the inhibition of pyruvate metabolism by a-cyano-4-hydroxycinnamate. 4. Parallel measurements of the mitochondrial membrane potential by using [3H]triphenylmethylphosphonium ions showed that it was elevated by about 3 mV after pretreatment of rats with both glucagon and phenylephrine. There was no significant change in the transmembrane pH gradient. 5. It is shown that the increase in pyruvate metabolism can be explained by a stimulation of the respiratory chain, producing an elevation in the protonmotive force and a consequent rise in the intramitochondrial ATP/ADP ratio, which in turn increases pyruvate carboxylase activity. 6. Mild inhibition of the respiratory chain with Amytal reversed the effects of hormone treatment on mitochondrial pyruvate metabolism and ATP concentrations, but not on citrulline synthesis. 7. The significance of these observations for the hormonal regulation of gluconeogenesis from L-lactate in vivo is discussed.
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Liver mitochondria isolated from rats pretreated with glucagon show enhanced rates of pyruvate carboxylation and decarboxylation (Adam & Haynes, 1969) . Since the activity of neither pyruvate carboxylase nor pyruvate dehydrogenase was altered by hormone treatment, it was suggested that pyruvate transport into the mitochondria was the site of hormonal stimulation. Subsequent work in our and other laboratories has supported this conclusion and led to the suggestion that transport is stimulated by an increase in transmembrane pH gradient (Titheradge & Coore, 1976a,b; Halestrap, 1977 Halestrap, , 1978b caused by the well-documented stimulation of respiratory-chain activity (Yamazaki, 1975; Halestrap, 1978a Halestrap, ,b, 1982 . This conclusion was largely based on the linear Dixon plots for a-cyano-4-hydroxycinnamate inhibition of pyruvate metabolism, which were taken to indicate that mitochondrial pyruvate transport was the rate-controlling step for pyruvate metabolism (Halestrap, 1978b; Halestrap et al., 1980 ; Thomas & Halestrap, 1981; Armston et al., 1982; Rognstad, 1983) .
However, Martin et al. (1984) report non-linear Dixon plots under their conditions for measuring mitochondrial metabolism. Furthermore, Groen et al. (1982, 1983) have pointed out that linear Dixon plots might occur even if pyruvate carboxylase rather than pyruvate transport is the controlling step for mitochondrial pyruvate metabolism. In support of this view, carboxylation of pyruvate generated inside the mitochondria from alanine is also stimulated in liver mitochondria from rats treated with glucagon (Chan et al., 1979) . Moreover, subsequent studies by Groen et al. (1983) from starved rats cannot be regulated by mitochondrial pyruvate transport. They point out that the apparent Ki for inhibition of pyruvate metabolism or gluconeogenesis by a-cyano-4-hydroxycinnamate should match the Ki found for pyruvate transport in isolated mitochondria before a regulatory role for the transporter can be asserted. Since the Ki of a-cyano-4-hydroxycinnamate for the pyruvate transporter is dependent both on the pH gradient and on the presence of other monocarboxylates, such as ketone bodies (Halestrap, 1978a; Halestrap et al., 1980; Thomas & Halestrap, 1981 ), this comparison is not possible.
In the present paper we circumvent this problem by using the exceptionally potent inhibitor of the pyruvate transporter, a-cyano-p-(1-phenylindol-3-yl)acrylate (Ki <10-8M). As indicated in the preceding paper (Shearman & Halestrap, 1984) , this inhibitor binds so tightly that it titrates out the carrier stoichiometrically until about 65% inhibition is reached. Titration of pyruvate metabolism with this inhibitor and measurement of intramitochondrial pyruvate concentrations during metabolism have been used to assess the potential of the transporter for controlling the rate of pyruvate metabolism. It is demonstrated that, contrary to our earlier conclusions (Halestrap, 1977 (Halestrap, , 1978b , mitochondrial pyruvate metabolism is not controlled by the rate of pyruvate transport. This conclusion is discussed in relation to the stimulation of net flux from pyruvate to phosphoenolpyruvate induced by hormones in the intact cell during gluconeogenesis from L-lactate. An important role for stimulation of the respiratory chain and consequent activation of pyruvate carboxylase is proposed.
Experimental Materials
Liver mitochondria were prepared from normal fed female Wistar rats (200-250g body wt.) as described previously (Halestrap, 1975) . Where hormone treatment was required, rats were anaesthetized by injection (intraperitoneal) of Sagatal (1ml/kg body wt.) and after 30min, where required, glucagon (0.4mg/kg) or phenylephrine (2.0mg/kg) dissolved in saline was injected (intraperitoneally), and the rats were left for a further 8 min (phenylephrine) or 15 min (glucagon) before removal of the liver.
Unless otherwise stated, all chemicals and biochemicals were obtained from the sources cited in Halestrap (1975) and Armston et al. (1982) . Radiochemicals were purchased from Amersham International, Amersham, Bucks, U.K. Glucagon was obtained from Serva Feinbiochemica, Heidelberg, West Germany, and L-phenylephrine from Sigma Chemical Co., Poole, Dorset, U.K.
Methods
Measurement ofpyruvate metabolism and carboxylation. The rates of pyruvate carboxylation and total pyruvate metabolism at 37°C were measured simultaneously in the same buffer as for oxygenelectrode studies but containing 12.5 mM-KHCO3 gassed with 02/CO2 (19:1) before addition of H14CO3-(100d.p.m./nmol) and pyruvate (2mM). Details have been published elsewhere (Whipps & Halestrap, 1984) . Incubations of mitochondria (2.5-5mg of protein/ml) were continued for 6min before termination by addition of HC104 (final concn. 2%, w/v) and analysis of the supernatant for pyruvate, ATP and acid-stable 14C. Citrulline synthesis was studied similarly (Whipps & Halestrap, 1984) , but pyruvate was omitted from the buffer, and 5 mM-NH4Cl, 5 mM-glutamate, 1 mM-Lmalate and 20mM-L-ornithine were added.
Measurement of intramitochondrial pyruvate concentration. The intramitochondrial concentration of pyruvate during metabolism was measured by an adaptation of the method described by Halestrap & Denton (1974) . The medium used for pyruvate-carboxylation studies (excluding H14CO3-) was supplemented with D-[1-14C]-mannitol (1 mM; 0.1 pCi/ml) and 3H20 (1 4Ci/ml).
To 8 ml of medium in a 20 ml sealed vessel was added approx. 30mg of mitochondrial protein before gassing with 02/C02 (19 1) and incubation for 2min at 37°C. At this time, six 1 ml samples were layered on top of silicone oil (sp.gr. 1.02; 200 M1) overlaying 50p1 of HC104 (5%, w/v) in a 1.5ml tube before rapid centrifugation at lOOOOg for 1 min. The supernatant was carefully removed and acidified with HC104 (final concn. 2%, w/v), and then the oil was removed and discarded. The remaining mitochondrial extract was diluted to 0.5 ml with water, and samples of the supernatant were assayed for 3H, 14C and pyruvate as described previously (Halestrap & Denton, 1974; . From these measurements, the intramitochondrial volume (3H20-[14C]mannitol space) and the amount of intramitochondrial pyruvate (expressed as the pyruvate -[14C]mannitol space) could be calculated (Halestrap & McGivan, 1979; . Two additional 1ml samples from the original incubation were centrifuged in the absence of silicone oil and HC104, and the resulting mitochondrial pellet was assayed for protein by a modified biuret reaction standardized with bovine serum albumin (Gornall et al., 1949) .
Measurement of the protonmotive force. Mitochondrial membrane potentials and transmembrane pH gradients were determined by using
[3H]phenylmethylphosphonium ions (1.0pM; 0.1 .uCi/ml) and [14C]5,5'-dimethyloxazolidine-2,4-dione (0.2mM; 0.1 uCi/ml) respectively (see Rottenberg, 1979; Holian & Wilson, 1980) . Three parallel incubations were set up under conditions similar to those used for measuring intramitochondrial pyruvate concentrations. All incubations were well gassed with 02/CO2 (19 :1) and also contained either [3H]triphenylmethylphosphonium iodide or [14C]5,5'-dimethyloxazolidine-2,4-dione and 3H20 (1 pCi/ml) or D-[1-14C]mannitol (1 mM; 0.1 uCi/ml) and 3H20
(1.OCi/ml). Mitochondria (approx. 4mg of protein/ml) were incubated for 2min at 37°C before removal of five 1 ml samples, which were centrifuged at IOOOOg for 1 min. One pellet was assayed for protein, and the remaining pellets were assayed for 14C and/or 3H in order to determine the uptake of [3H]triphenylmethylphosphonium or [14C]5,5'-dimethyloxazolidine-2,4-dione and the intramitochondrial volume (see Halestrap & McGivan, 1979; . From these the mitochondrial membrane potential and transmembrane pH gradient were calculated (Rottenberg, 1979) . Non-specific binding of [3H]triphenylmethylphosphonium was determined after addition of uncoupler. It was found to be less than 5% of the energized uptake and could be ignored without significant effect on the final result.
Computer simulation ofthe inhibition ofmitochondrial pyruvate metabolism by a-cyano-4-hydroxycinnamate. In order to assess the effects of a-cyano-4-hydroxycinnamate on mitochondrial pyruvate metabolism under conditions where pyruvate transport was not rate-limiting, computer simulations were performed by the procedure outlined previously (Thomas & Halestrap, 1981) to calculate the intramitochondrial pyruvate concentration. Eqn. (5) of Thomas & Halestrap (1981) was modified by inclusion of a diffusion constant for carrier-independent pyruvate transport rather than a fixed rate. From the estimated intramitochondrial pyruvate concentration, the rates of pyruvate carboxylation and oxidation were calculated from the relevant Km and Vmax. values.
Results and discussion
Inhibition by a-cyano-,B-(l-phenylindol-3-yl)acrylate of liver mitochondrial pyruvate carboxylation
The inhibition by a-cyano-f-(1-phenylindol-3-yl)acrylate of pyruvate carboxylation and total pyruvate metabolism by liver mitochondria from control and glucagon-treated animals is shown in Fig. 1 [a-Cyano-fl-(1-phenylindol-3-yl)acrylateI (uM) Fig. 1 . Inhibition by a-cyano-fi-(J-phenylindol-3-yl)acrylate of pyruvate metabolism by liver mitochondria from control and glucagon-treated rats, in bicarbonate medium Total pyruvate metabolism (0, *) and pyruvate carboxylation (A, V) by liver mitochondria from control (U, V) and glucagon-treated (0, A) rats were measured as described in the Experimental section. Each data point is the mean of duplicate observations. The mitochondrial protein concentrations were 3.59 (control) and 3.57 (glucagon) mg/ml. The dashed and dotted lines represent the extrapolated linear portion of the plots and the inhibitor-insensitive rate of metabolism respectively. From the intercepts, the concentrations of carrier molecules per mg of protein, estimated as described in the Experimental section, were 118 for control and 111 for glucagon-treated mitochondria. quired to give 50% inhibition was dependent on the protein concentration (results not shown), and extrapolation of the linear portion of the plot to zero rate of carrier-dependent metabolism (dotted line in Fig. 1 (Halestrap, 1978b; Armston et al., 1982) . We have repeated these experiments on numerous occasions and continue to obtain such linear plots, despite data to the contrary obtained by Martin et al. (1984) . Such (Thomas & Halestrap, 1981) , but reflecting the apparent Km for the enzyme under appropriate conditions of effectors and cofactors (Walsh et al., 1976) . This higher Km value was required to account for the equivalent decrease in both pyruvate carboxylation and total pyruvate metabolism at increasing inhibitor concentration. Although not strictly linear, the deviation from linearity predicted would be insufficient to be detected under our experimental conditions. There is also an increase in the apparent Ki from the real value (about 6 gM; Halestrap, 1975 Halestrap, , 1978a carboxylase. An increase in ATP/ADP ratio (see below) would be expected to increase the Vmax., and a fall in the Km would be predicted from the decrease in glutamate concentration after glucagon treatment (Siess et al., 1977; Siess & Wieland, 1978) , since this metabolite is a competitive inhibitor of pyruvate carboxylase (Scrutton & White, 1974 (Halestrap & McGivan, 1979) . . It should be noted that the changes in mitochondrial volume observed in situ and after rapid cell disruption are not observed consistently in mitochondria isolated by conventional techniques (Armston et al., 1982; Whipps & Halestrap, 1984 
Measurement of mitochondrial protonmotive force and A TP concentrations during metabolism
Previous data from this and other laboratories suggested that hormones stimulate mitochondrial pyruvate transport by increasing the transmembrane pH' gradient (Titheradge & Coore, 1976a,b; Halestrap, 1977 Halestrap, , 1978b . In addition, stimulation of pyruvate carboxylase by an increase in the intramitochondria ATP/ADP ratio has been implied (Bryla et al., 1977; Titheradge et al., 1979; Bryla & Niedzwiecka, 1979; Chan et al., 1979; Martin & Titheradge, 1983; Chisholm et al., 1983) . In previous experiments from this laboratory (Halestrap, 1977 (Halestrap, , 1978b Armston et al., 1982) , open containers were used for incubation of mitochondria when studying pyruvate metabolism. We have now established that rapid loss of CO2 during the incubation led to a rise in pH of the medium to 7.8-8.0. This probably accounts for the acid mitochondrial matrix observed under these conditions (Halestrap, 1978b) (Halestrap, 1978b treated animals were used in addition to glucagontreated animals to investigate the effects of aagonists on mitochondrial function. Such oCagonists appear to have the same effects as glucagon on mitochondrial function (Adam & Haynes, 1969; Garrison & Haynes, 1975; Titheradge & Coore, 1976b; Garrison & Borland, 1979; Titheradge et al., 1979; Titheradge & Haynes, 1980a; Halestrap, 1981; Allan et al., 1983) , and we have confirmed this in assays of citrulline synthesis, respiratory-chain activity and Ca2+-induced mitochondrial swelling (A. E. Armston & A. P. Halestrap, unpublished work mitochondria from control, glucagon-and phenylephrine-treated rats respectively. These values are similar to those measured in situ (Shulman et al., 1979; Hoek et al., 1980; Strzelecki et al., 1984) , and more recent data indicate no change in the value after hormone treatment of hepatocytes (Strzelecki et al., 1984) . In agreement with others (Bryla et al., 1977; Siess et al., 1977; Prpic et al., 1978; Titheradge et al., 1979; Taylor et al., 1980; Titheradge & Haynes, 1980a,b; Aprille et al., 1982; Chisholm et al., 1983) , the total adenine nucleotide content of mitochondria was shown to rise in liver mitochondria from glucagon-or phenylephrinetreated rats by about 25% (results not shown). As suggested by others (Bryla et al., 1977; Martin & Titheradge, 1983; Chisholm et al., 1983) , these data imply that it is the increase in mitochondrial ATP rather than a pH-driven stimulation of pyruvate transport that stimulates mitochondrial pyruvate carboxylation. The increase in ATP/ ADP ratio predicted for the observed change in protonmotive force can be calculated if it is assumed that 2H+ are required to synthesize 1 molecule of intramitochondrial ATP (Wander et al., 1981; Williamson et al., 1981) . A 5mV increase in protonmotive force would produce a 50% increase in mitochondrial ATP/ADP ratio. Taking into account the increase in total mitochondrial adenine nucleotides induced by hormone treatment, the observed changes in ATP content of metabolizing mitochondria are of the order predicted. Thus it would appear that it is the increase in protonmotive force that induces an increase in mitochondrial ATP/ADP ratio and that this causes the stimulation of pyruvate metabolism observed.
Role of the respiratory chain in hormonal effects on mitochondrial metabolism
The increase in protonmotive force induced by hormone treatment is thought to be secondary to the stimulation of the respiratory chain seen in liver mitochondria from hormone-treated rats (Yamazaki, 1975; Halestrap, 1978b Halestrap, , 1982 , and references therein), and there is a good correlation between the effects of glucagon on pyruvate metabolism and on the respiratory chain (Halestrap (1978b,c) . Thus it would be predicted that the hormone effects on mitochondrial pyruvate metabolism and ATP concentration could be reversed by mild inhibition of the respiratory chain. The data of Table 2 show that this is what is observed. (Table 2 ). This is to be expected, since at least part of the hormone's stimulation of citrulline synthesis is caused by elevated N-acetylglutamate concentrations (Hensgens et al., 1980; Rabier et al., 1982) , in addition to an effect of elevated ATP/ADP ratios (Bryla & Niedzwiecka, 1979; Titheradge & Haynes, 1980a,b; Goldstein & Aprille, 1982; Jensen et al., 1983; . Conclusions The data in the present paper indicate that our previous conclusion that hormone treatment of rats stimulates pyruvate metabolism in subsequently isolated mitochondria through an effect on pyruvate transport was erroneous. Rather it would seem that it is the effect of glucagon and phenylephrine to stimulate the respiratory chain (Yamazaki, 1975; Halestrap, 1978b Halestrap, ,c, 1982 (Halestrap, 1978b,c) . It is further confirmed by the effects of adding a low concentration of a respiratory-chain inhibitor to the glucagon-treated mitochondria, which causes them to behave like control mitochondria in relation to their ATP concentration and pyruvate metabolism ( Table 2) .
The question arises as to whether the stimulation of pyruvate metabolism seen in isolated mitochondria from glucagon-treated rats is relevant in vivo. Siess et al. (1981) have argued that results obtained in isolated mitochondria are artefacts, but this has been strongly challenged by others (Verhoeven et al., 1982; Jensen et al., 1983; Allan et al., 1983; Whipps & Halestrap, 1984) . Groen et al. (1983) concluded from experiments with perifused liver cells that, although pyruvate carboxylase has a high control strength, it is not the major site of regulation by glucagon. They ascribe pyruvate kinase to this role. However, the effect of glucagon on pyruvate kinase activity in hepatocytes from starved rats is small, since the enzyme is already greatly inhibited in the control cells under these conditions (Thomas & Halestrap, 1981) . Furthermore, a-agonists are without effect on the enzyme activity in starved cells (Thomas & Halestrap, 1981 ) and yet stimulate gluconeogenesis at the same locus as glucagon (Exton & Park, 1969; Chan & Exton, 1978) and have similar effects on mitochondrial function (see Armston, 1984) .
Computer simulation studies on the inhibition of gluconeogenesis in hepatocytes from starved animals by a-cyano-4-hydroxycinnamate are incompatible with control of gluconeogenesis residing in pyruvate kinase alone, but would support a role for pyruvate carboxylase on its own or in conjunction with pyruvate transport and pyruvate kinase (Thomas & Halestrap, 1981) . The data in the present paper make it unlikely that pyruvate transport is a regulatory step, as do the data of others (Siess et al., 1977; Tischler et al., 1977; Groen et al., 1983) , since the measured intramitochondrial pyruvate concentration approaches the equilibrium value in the hepatocyte as well as in isolated mitochondria. Unfortunately, we have been unable to use a-cyano-1-(l-phenylindol-3-yl)-acrylate to confirm this conclusion, since the inhibitor is too rapidly metabolized by liver cells. However, using the computer simulation techniques of Thomas & Halestrap (1981) , we have been able to simulate the linear and Dixon plots of a-cyano-4-hydroxycinnamate inhibition of gluconeogenesis under conditions where the Vmax.
for pyruvate transport was set at a value 5-10-fold in excess of that for pyruvate carboxylase (results not shown). The Kj value for the inhibitor used in the simulation was the determined value of 6pM (Halestrap, 1975) , although the apparent Kj value was 40-50pM, as was observed experimentally (Thomas & Halestrap, 1981) . Activation by hormones can be simulated by 45% stimulation of pyruvate carboxylase, which produced a 40% stimulation of gluconeogenesis. At a Hill coefficient of 2.5, changing the Km of pyruvate kinase from 0.8 to 1.4mM, as occurs after glucagon treatment of starved rats (Thomas & Halestrap, 1981) , produced a further increase in gluconeogenesis rate of 13%. This is insufficient to be the sole mechanism by which glucagon activates Vol. 223 gluconeogenesis, as suggested by Groen et al. (1982) , but it may explain the larger stimulatory effect of glucagon than of phenylephrine on gluconeogenesis. Thus pyruvate carboxylase remains the most likely locus of hormonal control.
Activation of the gluconeogenesis by glucagon or a-agonists occurs in isolated hepatocytes in conjunction with an increase in mitochondrial matrix volume (see Quinlan et al., 1983; . In isolated mitochondria, increasing the matrix volume increases both respiratory-chain activity and pyruvate metabolism (Armston et al., 1982; Halestrap, 1982) . Thus activation of mitochondrial pyruvate metabolism through an increased respiratory-chain activity would be expected in vivo. The observed increase in mitochondrial ATP/ADP ratios and acetyl-CoA concentrations and a fall in glutamate and 2-oxoglutarate concentrations (Siess et al., 1977; Siess & Wieland, 1978 Bryla et al., 1977; Titheradge et al., 1979; Jensen et al., 1983; Chisholm et al., 1983 ) could all be explained by a stimulation of the respiratory chain and would lead to activation of pyruvate carboxylase. In support of this, low concentrations of Amytal inhibit gluconeogenesis by isolated hepatocytes without affecting ATP concentration (Thomas & Halestrap, 1981) . Preliminary experiments indicate that the concentration of Amytal required to reverse the effects of glucagon on gluconeogenesis is exactly the same as that required to reverse the hormone's effect on the mitochondrial cytochrome spectra in hepatocytes (P. T. Quinlan & A. P. Halestrap, unpublished work). This work was supported by a project grant from the Medical Research Council.
